Evidence map›Paper›PMID 38228937›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2024

Genome analysis of Pseudomonas strain 4B with broad antagonistic activity against toxigenic fungi.

Flávio Fonseca Veras, Paolo Stincone, Juliane Elisa Welke, Ana Carolina Ritter, Franciele Maboni Siqueira, Ana Paula Muterle Varela, Fabiana Quoos Mayer, Adriano Brandelli

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Investigation of the biocontrol mechanism of a novelApplied and environmental microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Flávio Fonseca VerasDepartamento de Ciência de Alimentos, Instituto de Ciência E Tecnologia de Alimentos, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Paolo StinconeDepartamento de Ciência de Alimentos, Instituto de Ciência E Tecnologia de Alimentos, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Juliane Elisa WelkeDepartamento de Ciência de Alimentos, Instituto de Ciência E Tecnologia de Alimentos, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Ana Carolina RitterDepartamento de Ciência de Alimentos, Instituto de Ciência E Tecnologia de Alimentos, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Franciele Maboni SiqueiraLaboratório de Bacteriologia Veterinária, Departamento de Patologia Clínica Veterinária, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Ana Paula Muterle VarelaHospital Moinhos de Vento, Unidade de Educação, Porto Alegre, Brazil.
Fabiana Quoos MayerDepartamento de Biologia Molecular E Biotecnologia, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Adriano BrandelliDepartamento de Ciência de Alimentos, Instituto de Ciência E Tecnologia de Alimentos, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil. abrand@ufrgs.br.ORCID http://orcid.org/0000-0002-9307-6471
Universidade Federal do Rio Grande do Sul · BRHospital Moinhos de Vento · BRUniversidade Federal do Rio Grande · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 308880/2021-8Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul 19/2551-0001855-0
6 · The paper itself

Abstract

Pseudomonas sp. 4B isolated from the effluent pond of a bovine abattoir was investigated as antifungal against toxigenic fungi. The complete genome of Pseudomonas 4B was sequenced using the Illumina MiSeq platform. Phylogenetic analysis and genome comparisons indicated that the strain belongs to the Pseudomonas aeruginosa group. In silico investigation revealed gene clusters associated with the biosynthesis of several antifungals, including pyocyanin, rhizomide, thanamycin, and pyochelin. This bacterium was investigated through antifungal assays, showing an inhibitory effect against all toxigenic fungi tested. Bacterial cells reduced the diameter of fungal colonies, colony growth rate, and sporulation of each indicator fungi in 10-day simultaneous growing tests. The co-incubation of bacterial suspension and fungal spores in yeast extract-sucrose broth for 48 h resulted in reduced spore germination. During simultaneous growth, decreased production of aflatoxin B1 and ochratoxin A by Aspergillus flavus and Aspergillus carbonarius, respectively, was observed. Genome analysis and in vitro studies showed the ability of P. aeruginosa 4B to reduce fungal growth parameters and mycotoxin levels, indicating the potential of this bacterium to control toxigenic fungi. The broad antifungal activity of this strain may represent a sustainable alternative for the exploration and subsequent use of its possible metabolites in order to control mycotoxin-producing fungi.

Indexed as

Antifungal AgentsMycotoxinsAnimalsAspergillus flavusCattleFungiPhylogenyPseudomonasPseudomonas aeruginosaAntifungal AgentsMycotoxinsFungiGenomePseudomonas

Identifiers

PMID38228937
PMCPMC10920548
OpenAlexW4390928984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.